221 related articles for article (PubMed ID: 24244763)
1. Naturally acquired immune responses to P. vivax merozoite surface protein 3α and merozoite surface protein 9 are associated with reduced risk of P. vivax malaria in young Papua New Guinean children.
Stanisic DI; Javati S; Kiniboro B; Lin E; Jiang J; Singh B; Meyer EV; Siba P; Koepfli C; Felger I; Galinski MR; Mueller I
PLoS Negl Trop Dis; 2013 Nov; 7(11):e2498. PubMed ID: 24244763
[TBL] [Abstract][Full Text] [Related]
2. Induction and Kinetics of Complement-Fixing Antibodies Against Plasmodium vivax Merozoite Surface Protein 3α and Relationship With Immunoglobulin G Subclasses and Immunoglobulin M.
Oyong DA; Wilson DW; Barber BE; William T; Jiang J; Galinski MR; Fowkes FJI; Grigg MJ; Beeson JG; Anstey NM; Boyle MJ
J Infect Dis; 2019 Nov; 220(12):1950-1961. PubMed ID: 31419296
[TBL] [Abstract][Full Text] [Related]
3. Strain-specific duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous plasmodium vivax strains in Papua New Guinean children.
Cole-Tobian JL; Michon P; Biasor M; Richards JS; Beeson JG; Mueller I; King CL
Infect Immun; 2009 Sep; 77(9):4009-17. PubMed ID: 19564376
[TBL] [Abstract][Full Text] [Related]
4. Anti-Plasmodium vivax merozoite surface protein 3 ϒ (PvMSP3 ϒ) antibodies upon natural infection.
Kuamsab N; Putaporntip C; Kakino A; Kosuwin R; Songsaigath S; Tachibana H; Jongwutiwes S
Sci Rep; 2024 Apr; 14(1):9595. PubMed ID: 38671033
[TBL] [Abstract][Full Text] [Related]
5. An Antibody Screen of a Plasmodium vivax Antigen Library Identifies Novel Merozoite Proteins Associated with Clinical Protection.
França CT; Hostetler JB; Sharma S; White MT; Lin E; Kiniboro B; Waltmann A; Darcy AW; Li Wai Suen CS; Siba P; King CL; Rayner JC; Fairhurst RM; Mueller I
PLoS Negl Trop Dis; 2016 May; 10(5):e0004639. PubMed ID: 27182597
[TBL] [Abstract][Full Text] [Related]
6. Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical Malaria.
He WQ; Shakri AR; Bhardwaj R; França CT; Stanisic DI; Healer J; Kiniboro B; Robinson LJ; Guillotte-Blisnick M; Huon C; Siba P; Cowman A; King CL; Tham WH; Chitnis CE; Mueller I
PLoS Negl Trop Dis; 2019 Feb; 13(2):e0006987. PubMed ID: 30768655
[TBL] [Abstract][Full Text] [Related]
7. Naturally-acquired humoral immune responses against the N- and C-termini of the Plasmodium vivax MSP1 protein in endemic regions of Brazil and Papua New Guinea using a multiplex assay.
Fernandez-Becerra C; Sanz S; Brucet M; Stanisic DI; Alves FP; Camargo EP; Alonso PL; Mueller I; del Portillo HA
Malar J; 2010 Jan; 9():29. PubMed ID: 20092651
[TBL] [Abstract][Full Text] [Related]
8. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection.
King CL; Michon P; Shakri AR; Marcotty A; Stanisic D; Zimmerman PA; Cole-Tobian JL; Mueller I; Chitnis CE
Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8363-8. PubMed ID: 18523022
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of the Plasmodium vivax merozoite surface protein 1 paralog in the induction of naturally acquired antibody and memory B cell responses.
Min HMK; Changrob S; Soe PT; Han JH; Muh F; Lee SK; Chootong P; Han ET
Malar J; 2017 Aug; 16(1):354. PubMed ID: 28854974
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium vivax VIR Proteins Are Targets of Naturally-Acquired Antibody and T Cell Immune Responses to Malaria in Pregnant Women.
Requena P; Rui E; Padilla N; Martínez-Espinosa FE; Castellanos ME; Bôtto-Menezes C; Malheiro A; Arévalo-Herrera M; Kochar S; Kochar SK; Kochar DK; Umbers AJ; Ome-Kaius M; Wangnapi R; Hans D; Menegon M; Mateo F; Sanz S; Desai M; Mayor A; Chitnis CC; Bardají A; Mueller I; Rogerson S; Severini C; Fernández-Becerra C; Menéndez C; Del Portillo H; Dobaño C
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005009. PubMed ID: 27711158
[TBL] [Abstract][Full Text] [Related]
11. B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax merozoite surface protein-3α (PvMSP-3α) in malaria exposed individuals from Brazilian Amazon.
Lima-Junior JC; Jiang J; Rodrigues-da-Silva RN; Banic DM; Tran TM; Ribeiro RY; Meyer VS; De-Simone SG; Santos F; Moreno A; Barnwell JW; Galinski MR; Oliveira-Ferreira J
Vaccine; 2011 Feb; 29(9):1801-11. PubMed ID: 21215342
[TBL] [Abstract][Full Text] [Related]
12. Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 9 in Northwestern Amazon individuals.
Lima-Junior JC; Tran TM; Meyer EV; Singh B; De-Simone SG; Santos F; Daniel-Ribeiro CT; Moreno A; Barnwell JW; Galinski MR; Oliveira-Ferreira J
Vaccine; 2008 Dec; 26(51):6645-54. PubMed ID: 18832003
[TBL] [Abstract][Full Text] [Related]
13. Naturally acquired antibodies to Plasmodium vivax blood-stage vaccine candidates (PvMSP-1₁₉ and PvMSP-3α₃₅₉₋₇₉₈ and their relationship with hematological features in malaria patients from the Brazilian Amazon.
Mourão LC; Morais CG; Bueno LL; Jimenez MC; Soares IS; Fontes CJ; Guimarães Lacerda MV; Xavier MS; Barnwell JW; Galinski MR; Braga EM
Microbes Infect; 2012 Aug; 14(9):730-9. PubMed ID: 22445906
[TBL] [Abstract][Full Text] [Related]
14. Malaria transmission and individual variability of the naturally acquired IgG antibody against the Plasmodium vivax blood-stage antigen in an endemic area in Brazil.
Costa EMF; Amador ECC; Silva ES; Alvarenga CO; Pereira PE; Póvoa MM; Cunha MG
Acta Trop; 2020 Sep; 209():105537. PubMed ID: 32454033
[TBL] [Abstract][Full Text] [Related]
15. Naturally Acquired Antibody Responses to Plasmodium vivax and Plasmodium falciparum Merozoite Surface Protein 1 (MSP1) C-Terminal 19 kDa Domains in an Area of Unstable Malaria Transmission in Southeast Asia.
Wang Q; Zhao Z; Zhang X; Li X; Zhu M; Li P; Yang Z; Wang Y; Yan G; Shang H; Cao Y; Fan Q; Cui L
PLoS One; 2016; 11(3):e0151900. PubMed ID: 26999435
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein.
Grimberg BT; Udomsangpetch R; Xainli J; McHenry A; Panichakul T; Sattabongkot J; Cui L; Bockarie M; Chitnis C; Adams J; Zimmerman PA; King CL
PLoS Med; 2007 Dec; 4(12):e337. PubMed ID: 18092885
[TBL] [Abstract][Full Text] [Related]
17. Comparison of naturally acquired antibody responses against the C-terminal processing products of Plasmodium vivax Merozoite Surface Protein-1 under low transmission and unstable malaria conditions in Sri Lanka.
Wickramarachchi T; Illeperuma RJ; Perera L; Bandara S; Holm I; Longacre S; Handunnetti SM; Udagama-Randeniya PV
Int J Parasitol; 2007 Feb; 37(2):199-208. PubMed ID: 17055511
[TBL] [Abstract][Full Text] [Related]
18. Differential impact of malaria control interventions on P. falciparum and P. vivax infections in young Papua New Guinean children.
Ome-Kaius M; Kattenberg JH; Zaloumis S; Siba M; Kiniboro B; Jally S; Razook Z; Mantila D; Sui D; Ginny J; Rosanas-Urgell A; Karl S; Obadia T; Barry A; Rogerson SJ; Laman M; Tisch D; Felger I; Kazura JW; Mueller I; Robinson LJ
BMC Med; 2019 Dec; 17(1):220. PubMed ID: 31813381
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of naturally acquired immune responses against novel pre-erythrocytic Plasmodium vivax proteins in a low endemic malaria population located in the Peruvian Amazon Basin.
Ventocilla JA; Tapia LL; Ponce R; Franco A; Leelawong M; Aguiar JC; Baldeviano GC; Wilder BK
Malar J; 2024 May; 23(1):163. PubMed ID: 38783317
[TBL] [Abstract][Full Text] [Related]
20. Acquired antibody responses against Plasmodium vivax infection vary with host genotype for duffy antigen receptor for chemokines (DARC).
Maestre A; Muskus C; Duque V; Agudelo O; Liu P; Takagi A; Ntumngia FB; Adams JH; Sim KL; Hoffman SL; Corradin G; Velez ID; Wang R
PLoS One; 2010 Jul; 5(7):e11437. PubMed ID: 20664684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
